FACTORS ASSOCIATED WITH ASYMPTOMATIC COVID-19 INFECTION IN A DISTRICT SETTING IN MALAYSIA
We aimed to determine the prevalence, characteristics, and risk factors associated with asymptomatic COVID-19 cases in a district setting in Malaysia. We included all confirmed COVID-19 cases within the district from inception to March 2021. Out of 3,051 confirmed COVID-19 cases, 1,862 (61.0%) were asymptomatic. Asymptomatic cases were mostly men, younger, non-Malaysians and had fewer comorbidities. The highest prevalence of asymptomatic cases was from prisons and factories. Male gender (adjusted OR 2.02; 95%CI 1.69 – 2.43), non-Malaysians (adjusted OR 20.00; 95%CI 14.75 – 27.64), current smoking status (adjusted OR 12.06; 95%CI 6.74 – 23.94), prisoners (adjusted OR 19.02; 95%CI 12.30 – 30.57), and higher CT values were significantly associated with asymptomatic COVID-19 infection. To ensure more targeted public health prevention and infection containment strategies, authorities and employers should be more aware of their local population's heterogeneity, risk factors, and unique conditions.
Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency. Revista Clínica Española (English Edition). 2021 2021/01/01/;221(1):55-61.
World Health Organization. COVID-19 weekly epidemiological update, edition 45, 22 June 2021.
Malaysia Department of Statistics. Population & Demography Department of Statistics Malaysia Official Portal 2021 [28/08/2021]. Available from: https://www.dosm.gov.my/v1/index.php?r=column/ctwoByCat&parent_id=115&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09
COVID-19 Tracker: Malaysia Reuters2021 [28/08/2021]. Available from: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/malaysia/
Ministry of Health, Malaysia. Kenyataan Akhbar KPK 18 ogos 2021 – Situasi Semasa Jangkitan Penyakit Coronavirus 2019 (COVID-19) DI Malaysia 2021 [cited 19 August, 2021]. Available from: https://kpkesihatan.com/2021/08/18/kenyataan-akhbar-kpk-18-ogos-2021-situasi-semasa-jangkitan-penyakit-coronavirus-2019-covid-19-di-malaysia/
Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020;41(12):1100-1115.
McAloon C, Collins Á, Hunt K, Barber A, Byrne AW, Butler F, et al. Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open. 2020 Aug 16;10(8):e039652.
Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278-280.
Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2020 2020/12/01;5(4):223-234.
Alene M, Yismaw L, Assemie MA, Ketema DB, Mengist B, Kassie B, et al. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis. PLOS ONE. 2021;16(3):e0249090.
Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, et al. SARS-CoV-2 Transmission From People Without COVID-19 Symptoms. JAMA Netw Open. 2021 Jan 4;4(1):e2035057.
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2021;54(1):12-16.
Aguilar JB, Faust JS, Westafer LM, Gutierrez JB. Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission. medRxiv. 2020:2020.03.18.20037994.
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. Journal of Microbiology, Immunology and Infection. 2021 2021/02/01/;54(1):12-16.
Ministry of Health, Malaysia. COVID-19 case definition [cited 1 September, 2021]. Available from: https://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm/ANNEX_1-Case_definition_11052021.pdf
Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA: A Cancer Journal for Clinicians. 2016;66(4):337-350.
Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Family Medicine and Community Health. 2020;8(1):e000262.
Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS medicine. 2020;17(9):e1003346.
Galbadage T, Peterson BM, Awada J, Buck AS, Ramirez DA, Wilson J, et al. Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes. Frontiers in medicine. 2020;7:348.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of infection. 2020;81(2):e16-e25.
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel medicine and infectious disease. 2020;34:101623.
Jayakumar G. Pre-Employment Medical Examination of Migrant Workers-The Ethical and Legal Issues. Medical Journal of Malaysia. 2006;61(5):516.
Zhang Z. Cigarette smoking as a risk factor for acute respiratory distress syndrome: a systematic review and meta-analysis. PeerJ PrePrints. 2014;2:e574v1.
Ministry of Health, Malaysia. National Health Morbidity Survey 2019. Non-Communicable Diseases : Risk Factors and other Health Problems Technical Report Volume 1: National Institutes of Health (NIH), Ministry of Health Malaysia; 2019.
Usman MS, Siddiqi TJ, Khan MS, Patel UK, Shahid I, Ahmed J, et al. Is there a smoker’s paradox in COVID-19? BMJ evidence-based medicine. 2020.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. New England Journal of Medicine. 2020;382(24):2372-2374.
Williamson E, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton E, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv. 2020:2020.05.06.20092999.
Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature. 2003;421(6921):384-388.
Vleeming W, Rambali B, Opperhuizen A. The role of nitric oxide in cigarette smoking and nicotine addiction. Nicotine & tobacco research. 2002;4(3):341-348.
Simpson PL, Butler TG. Covid-19, prison crowding, and release policies. BMJ. 2020;369:m1551.
Simpson PL, Simpson M, Adily A, Grant L, Butler T. Prison cell spatial density and infectious and communicable diseases: a systematic review. BMJ Open. 2019;9(7):e026806.
Dutheil F, Bouillon-Minois J-B, Clinchamps M. COVID-19: a prison-breaker? Canadian Journal of Public Health. 2020 2020/08/01;111(4):480-481.
Mariano C, Lina C, Nunzia C, Piergiorgio F. The COVID-19 Epidemic and the Prison System in Italy. Journal of Correctional Health Care. 2021;27(1):3-7.
Novisky MA, Narvey CS, Semenza DC. Institutional Responses to the COVID-19 Pandemic in American Prisons. Victims & Offenders. 2020 2020/10/02;15(7-8):1244-1261.
Linda So GS. In four U.S. state prisons, nearly 3,300 inmates test positive for coronavirus -96% without symptoms. Reuters 2020.
Khalid MA. COVID-19: Malaysia Experience and Key Lessons. Asian Economic Papers. 2021;20(2):73-95.
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.
Dramé M, Tabue Teguo M, Proye E, Hequet F, Hentzien M, Kanagaratnam L, et al. Should RT‐PCR be considered a gold standard in the diagnosis of Covid‐19? Journal of medical virology. 2020;92(11):2312-2313.
Rao SN, Manissero D, Steele VR, Pareja J. A Narrative Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19. Infectious Diseases and Therapy. 2020 2020/09/01;9(3):573-586.
Rao SN, Manissero D, Steele VR, Pareja J. A narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infectious diseases and therapy. 2020:1-14.
Salvatore PP, Dawson P, Wadhwa A, Rabold EM, Buono S, Dietrich EA, et al. Epidemiological correlates of PCR cycle threshold values in the detection of SARS-CoV-2. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2020.
Singanayagam A, Patel M, Charlett A, Lopez Bernal J, Saliba V, Ellis J, et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Eurosurveillance. 2020;25(32):2001483. doi: doi:https://doi.org/10.2807/1560-7917.ES.2020.25.32.2001483.
Government of Malaysia. Undang-Undang Malaysia: Akta Pencegahan dan Kawalan Penyakit Berjangkit 1988 (Act 342). Kuala Lumpur, Malaysia; 1988.